Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-01-01 @ 12:54 PM
Study NCT ID:
NCT01563068
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2012-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
Sponsor:
Mayne Pharma International Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-15
First Submit QC Date:
None
Study First Post Date:
2012-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-08
Last Update Post Date:
2018-05-11
Last Update Post Date Type:
ACTUAL